StockData
Pfizer Inc logo

Pfizer Inc

PFENYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Aug 4, 2026Score 11/3053% above fair value
$30.67+0.15 (+0.49%)

Close on Nov 2, 2026Market cap $174.81BP/E 40.4Yield 5.61%

Pfizer Blockbuster Medicines & Vaccines by Year

Blockbuster Medicines & Vaccines (>$1B Annual Revenue) — Product count

Pfizer Blockbuster Medicines & Vaccines: 12 in FY2025, up 9.1% from a year earlier. That is the highest of the 10 years on record here.

Latest, FY2025
12
Period ended Dec 31, 2025
Change on a year earlier
+9.1%
11 in FY2024
History
10 years
Since FY2016
Sources
8
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-26) ↗

Reported in Form 10-K Note 17 — Significant Customers & Geographic Concentration.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedBlockbuster Medicines & Vaccines (>$1B Annual Revenue) — Product countYear on yearSource
FY2025Dec 31, 202512+9.1%Form 10-K (filed 2026-02-26) ↗
FY2024Dec 31, 202411+22.2%Form 10-K (filed 2026-02-26) ↗
FY2023Dec 31, 20239-10.0%Form 10-K (filed 2026-02-26) ↗
FY2022Dec 31, 202210+11.1%Form 10-K (filed 2025-02-27) ↗
FY2021Dec 31, 20219+28.6%Form 10-K (filed 2024-02-22) ↗
FY2020Dec 31, 20207+16.7%Form 10-K (filed 2023-02-23) ↗
FY2019Dec 31, 20196-14.3%Form 10-K (filed 2022-02-24) ↗
FY2018Dec 31, 20187-22.2%Form 10-K (filed 2021-02-25) ↗
FY2017Dec 31, 201790.0%Form 10-K (filed 2020-02-27) ↗
FY2016Dec 31, 20169–Form 10-K (filed 2019-02-28) ↗

Breakdown

What makes up blockbuster Medicines & Vaccines

Cite this data

StockData. (2026). Pfizer Blockbuster Medicines & Vaccines, annual FY2016–FY2025 [Data set]. Compiled from Pfizer SEC filings and investor materials. https://stockdatahq.com/stocks/pfe/kpis/conc-blockbuster-cnt

See every metric in the Pfizer KPI table. Data updated Nov 2, 2026.